(Q34763634)

4 August 2017

1 reference

title

The story of the discovery of heparin and warfarin (English)

1 reference

4 August 2017

1 reference

1 reference

Douglas Wardrop

1

1 reference

4 August 2017

David Keeling

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

18 March 2008

1 reference

British Journal of Haematology

4 August 2017

published in

1 reference

4 August 2017

volume

141

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

757-763

1 reference

The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The status of new anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The oral anticoagulant saga: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The missing link: the story of Karl Paul Link

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

William Henry Howell and Jay McLean: the experimental context for the discovery of heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The development of heparin in Toronto.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The origin of the dispute over the discovery of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

Warfarin: almost 60 years old and still causing problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07119.X

10.1111/J.1365-2141.2008.07119.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference